Introduction
============

Lactulose was reported to inhibit gastric tone and motility in healthy volunteers \[[@B1]\]. Double blind placebo controlled study using lactulose four times 15 ml daily (ie 40 g) or saline for prevention of ventilator associated pneumonia was performed in our ICU during 1999-2000. In this report the impact on gastric feeding tolerance of lactulose given into stomach is evaluated.

Materials and methods
=====================

Forty-eight patients without pneumonia and mechanically ventilated for \< 24 hours entered the study. From day 2 EN was given by a standardised protocol into the stomach. Daily amount of enteral nutrition (EN) was recorded. Failure was defined as EN interruption \> 24 hours because of large residuals. Metoclopramide was used in all patients.

Statistics
==========

Chi-square and Mann-Whitney *U*-tests when appropriate. Data presented as means ± SD. *P* \< 0.05 was considered significant.

Results
=======

Thirty-eight patients in whom EN was not contraindicated and stayed in the ICU \> 3 days were analysed. Fifteen patients received lactulose (L) and 23 were given placebo (P). L and P groups did not differ in age (50.3 ± 18.2 and 52.7 ± 16.3; NS), APACHE II on admission (24.7 ± 8.7 and 26.0 ± 7.3; NS). There also was no difference in L and P groups in mortality (6 ICU survivors and 9 non-survivors in lactulose group and 13 non-survivors and 10 survivors in placebo group; NS), length of ICU stay (LOS) (13.5 ± 7.4 and 15.2 ± 11.0; NS) and ventilatory days (12.5 ± 6.8 and 12.0 ± 7.8; NS). Patients receiving L did not differ from P in daily tolerance of gastric feeding (604 ± 438 and 425 ± 264 ml/day; *P* = 0.16) and number of EN intolerances per hospitalisation (0.51 ± 0.26 and 0.50 ± 0.35 intolerances/LOS; NS). This was also true when ICU survivors were analysed separately.

Conclusions
===========

Lactulose administered into the stomach has no impact on poor tolerance of gastric feeding in mechanically ventilated long term ICU patients.
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